Very low-dose (0.15 mGy) chest CT protocols using the COPDGene 2 Test object and a third-generation dual-source CT scanner with corresponding third-generation iterative reconstruction software

Investigative Radiology

Volumn 50, Issue 1, 2015, Pages 40-45

  Newell, John D ^a,b   Fuld, Matthew K ^c   Allmendinger, Thomas ^c   Sieren, Jered P ^a   Chan, Kung Sik ^d   Guo, Junfeng ^a   Hoffman, Eric A ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b University of Iowa   (United States)

^c SIEMENS AG   (Germany)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

Computed tomography; COPD; Emphysema; Lung imaging; Phantom; Quantitative CT; Radiation dose; Test object

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; COMPUTED TOMOGRAPHY SCANNER; DENSITOMETRY; DOSE RESPONSE; HUMAN; IMAGE QUALITY; LUNG DISEASE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PHENOTYPE; PRIORITY JOURNAL; RADIATION DOSE; RADIOTHERAPY SOFTWARE; REFERENCE VALUE; RUNNING ADVANCED MODELED ITERATIVE RECONSTRUCTION SOFTWARE; SIGNAL NOISE RATIO; THIRD GENERATION DUAL SOURCE CT SCANNER; THORAX RADIOGRAPHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; EVALUATION STUDY; IMAGE ENHANCEMENT; IMAGE PROCESSING; IMAGING PHANTOM; LUNG; PROCEDURES; SOFTWARE;

HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG; MULTIDETECTOR COMPUTED TOMOGRAPHY; PHANTOMS, IMAGING; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RADIATION DOSAGE; RADIOGRAPHIC IMAGE ENHANCEMENT; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; SOFTWARE;

EID: 84925957062     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0000000000000093     Document Type: Article

References (21)

1. Gordic S, Morsbach F, Schmidt B, et al. Ultralow-dose chest computed tomography for pulmonary nodule detection: first performance evaluation of single energy scanning with spectral shaping. Invest Radiol. 2014;49:465-473.
2. Sarma A, Heilbrun ME, Conner KE, et al. Radiation and chest CT scan examinations: what do we know? Chest. 2012;142:750-760.
3. Huda W, Schoepf UJ, Abro JA, et al. Radiation-related cancer risks in a clinical patient population undergoing cardiac CT. AJR Am J Roentgenol. 2011;196: W159-W165.
4. Aberle DR, DeMello S, Berg CD, et al. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med. 2013;369:920-931.
5. Church TR, Black WC, Aberle DR, et al. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med. 2013;368:1980-1991.
6. Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl JMed. 2011;365:395-409.
7. Aberle DR, Berg CD, Black WC, et al. The National Lung Screening Trial: overview and study design. Radiology. 2011;258:243-253.
8. Fan L, Xia Y, Guan Y, et al. Characteristic features of pulmonary function test, CT volume analysis and MR perfusion imaging in COPD patients with different HRCT phenotypes. Clin Respir J. 2014;8:45-54.
9. Hansel NN, Washko GR, Foreman MG, et al. Racial differences in CT phenotypes in COPD. COPD. 2013;10:20-27.
10. Van Tho N,Wada H, Ogawa E, et al. Recent findings in chronic obstructive pulmonary disease by using quantitative computed tomography. Respir Invest. 2012; 50:78-87.
11. Mets OM, de Jong PA, van Ginneken B, et al. Quantitative computed tomography in COPD: possibilities and limitations. Lung. 2012;190:133-145.
12. Martinez CH, Chen YH,Westgate PM, et al. Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease. Thorax. 2012;67:399-406.
13. Rutten EP, Grydeland TB, Pillai SG, et al. Quantitative CT: associations between emphysema, airway wall thickness and body composition in COPD. Pulm Med. 2011;2011:419328.
14. Kim WJ, Hoffman E, Reilly J, et al. Association of COPD candidate genes with computed tomography emphysema and airway phenotypes in severe COPD. Eur Respir J. 2011;37:39-43.
15. Han MK, Kazerooni EA, Lynch DA, et al. Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology. 2011;261:274-282.
16. Newell JD Jr, Sieren J, Hoffman EA. Development of quantitative computed tomography lung protocols. J Thorac Imaging. 2013;28:266-271.
17. Sieren JP, Newell JD, Judy PF, et al. Reference standard and statistical model for intersite and temporal comparisons of CTattenuation in a multicenter quantitative lung study. Med Phys. 2012;39:5757-5767.
18. Sieren JP, Chan KS, Guo J, et al. Influence of radiation dose on mean CT values of lung equivalent foam and other relevant materials contained in the COPDGene 2 test object when reconstructing ct projection data with sinogram affirmed iterative reconstruction (SAFIRE) versus weighted filtered back projection (WFBP). Am J Respir Crit Care Med. 2013;187:A4876.
19. Sieren JP, Hoffman EA, Fuld MK, et al. Sinogram affirmed iterative reconstruction (SAFIRE) versus weighted filtered back projection (WFBP) effects on quantitative measure in the COPD gene 2 test object. Med Phys. 2014.
20. Pickhardt PJ, Lubner MG, Kim DH, et al. Abdominal CTwith model-based iterative reconstruction (MBIR): initial results of a prospective trial comparing ultralow-dose with standard-dose imaging. AJR Am J Roentgenol. 2012;199: 1266-1274.
21. Thibault JB, Sauer KD, Bouman CA, et al. A three-dimensional statistical approach to improved image quality for multislice helical CT. Med Phys. 2007;34:4526-4544.